Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications
- PMID: 20058265
- PMCID: PMC2809802
- DOI: 10.1002/iub.293
Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications
Abstract
Agonist-selective signaling or ligand-biased signaling of G protein-coupled receptor (GPCR) has become the focus of an increasing number of laboratories. The principle of this concept is that agonist possesses different abilities to activate different signaling pathways. Current review summarizes the observations of agonist-selective signaling of various GPCRs, indicating the significance of agonist-selective signaling in biological processes. In addition, current review also provides an overview on how agonist-selective signaling is initiated. Especially, the relationship between GPCR-G protein interaction and GPCR-beta-arrestin interaction is discussed in depth.
(c) 2010 IUBMB IUBMB Life.
Figures


Similar articles
-
Heptahelical terpsichory. Who calls the tune?J Recept Signal Transduct Res. 2008;28(1-2):39-58. doi: 10.1080/10799890801941921. J Recept Signal Transduct Res. 2008. PMID: 18437629 Review.
-
Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.J Neurochem. 2009 Jul;110(2):662-74. doi: 10.1111/j.1471-4159.2009.06156.x. Epub 2009 May 8. J Neurochem. 2009. PMID: 19457093 Free PMC article.
-
Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1448-53. doi: 10.1073/pnas.0409534102. Epub 2005 Jan 25. Proc Natl Acad Sci U S A. 2005. PMID: 15671180 Free PMC article.
-
The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.J Cell Sci. 2002 Feb 1;115(Pt 3):455-65. doi: 10.1242/jcs.115.3.455. J Cell Sci. 2002. PMID: 11861753 Review.
-
β-arrestin-mediated signaling improves the efficacy of therapeutics.J Pharmacol Sci. 2012;118(4):408-12. doi: 10.1254/jphs.11r10cp. Epub 2012 Mar 23. J Pharmacol Sci. 2012. PMID: 22447307 Review.
Cited by
-
Signal protein-derived peptides as functional probes and regulators of intracellular signaling.J Amino Acids. 2011;2011:656051. doi: 10.4061/2011/656051. Epub 2011 Aug 23. J Amino Acids. 2011. PMID: 22312467 Free PMC article.
-
Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems.Front Pharmacol. 2017 Nov 10;8:794. doi: 10.3389/fphar.2017.00794. eCollection 2017. Front Pharmacol. 2017. PMID: 29209205 Free PMC article.
-
Non-Coding RNAs Regulating Morphine Function: With Emphasis on the In vivo and In vitro Functions of miR-190.Front Genet. 2012 Jun 15;3:113. doi: 10.3389/fgene.2012.00113. eCollection 2012. Front Genet. 2012. PMID: 22715342 Free PMC article.
-
3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.Biochem Pharmacol. 2013 Feb 1;85(3):404-16. doi: 10.1016/j.bcp.2012.11.015. Epub 2012 Dec 3. Biochem Pharmacol. 2013. PMID: 23219934 Free PMC article.
-
Consensus 3D model of μ-opioid receptor ligand efficacy based on a quantitative Conformationally Sampled Pharmacophore.J Phys Chem B. 2011 Jun 9;115(22):7487-96. doi: 10.1021/jp202542g. Epub 2011 May 12. J Phys Chem B. 2011. PMID: 21563754 Free PMC article.
References
-
- Ariens EJ. Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory. Arch Int Pharmacodyn Ther. 1954;99:32–49. - PubMed
-
- Furchgott R. The use of haloalkylamines in the differentiation of receptors and in the determination of dissciationof receptor-agonist complexes. Adv Drug Res. 1966;3:21–55. Harper NJ and Simmonds AB eds.
-
- Kenakin T. Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci. 1995;16:188–92. - PubMed
-
- Kenakin T. Pharmacological proteus? Trends Pharmacol Sci. 1995;16:256–8. - PubMed
-
- Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther. 2007;320:1–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA007339/DA/NIDA NIH HHS/United States
- R01 DA016674/DA/NIDA NIH HHS/United States
- K05 DA000513/DA/NIDA NIH HHS/United States
- R56 DA000564/DA/NIDA NIH HHS/United States
- K05-DA00513/DA/NIDA NIH HHS/United States
- K05 DA070554/DA/NIDA NIH HHS/United States
- DA016674/DA/NIDA NIH HHS/United States
- DA011806/DA/NIDA NIH HHS/United States
- DA000564/DA/NIDA NIH HHS/United States
- R01 DA000564/DA/NIDA NIH HHS/United States
- K05-DA70544/DA/NIDA NIH HHS/United States
- P50 DA011806/DA/NIDA NIH HHS/United States
- R01 DA007339/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources